Long-term Safety and Efficacy of Eculizumab in Asian Patients With Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder

被引：0

作者：

Fujihara, K. ^{[1
,2
,3
]}

Berthele, A. ^{[4
]}

Kim, H. J. ^{[5
]}

Levy, M. ^{[6
,7
,8
]}

Palace, J. ^{[9
]}

Nakashima, I. ^{[1
,10
]}

Totolyan, N. ^{[11
]}

Viswanathan, S. ^{[12
]}

Wang, K-C. ^{[13
,14
]}

Pace, A. ^{[15
]}

Armstrong, R. ^{[15
]}

Carrillo-Infante, C. ^{[15
]}

Miller, L. ^{[15
]}

Wingerchuk, D. M. ^{[16
]}

Pittock, S. J. ^{[17
]}

机构：

[1] Tohoku Univ, Sendai, Miyagi, Japan

[2] Fukushima Med Univ, Fukushima, Japan

[3] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Fukushima, Japan

[4] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany

[5] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea

[6] Johns Hopkins Univ, Baltimore, MD USA

[7] Massachusetts Gen Hosp, Boston, MA 02114 USA

[8] Harvard Med Sch, Boston, MA 02115 USA

[9] John Radcliffe Hosp, Oxford, England

[10] Tohoku Med & Pharmaceut Univ, Sendai, Miyagi, Japan

[11] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia

[12] Kuala Lumpur Hosp, Kuala Lumpur, Malaysia

[13] Cheng Hsin Gen Hosp, Taipei, Taiwan

[14] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan

[15] Alexion Pharmaceut, Boston, MA USA

[16] Mayo Clin, Scottsdale, AZ USA

[17] Mayo Clin, Rochester, MN USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P-106

引用

页码：NP84 / NP85

页数：2

共 50 条

[1] Long-term efficacy and safety of eculizumab in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder
Wingerchuk, Dean
Berthele, Achim
Fujihara, Kazuo
Oreja-Guevara, Celia
Kim, Ho Jin
Levy, Michael
Nakashima, Ichiro
Palace, Jacqueline
Shang, Shulian
Yountz, Marcus
Miller, Larissa
Pittock, Sean
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[2] Long-Term Visual Prognosis in Patients With Aquaporin-4-Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
Moon, Yeji
Jang, Yeonji
Lee, Haeng-Jin
Kim, Sung-Min
Kim, Seong-Joon
Jung, Jae Ho
JOURNAL OF NEURO-OPHTHALMOLOGY, 2022, 42 (03) : 303 - 309
[3] Evidence of Muller Glial Dysfunction in Patients with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
You, Yuyi
Zhu, Ling
Zhang, Ting
Shen, Ting
Fontes, Ariadna
Yiannikas, Con
Parratt, John
Barton, Joshua
Schulz, Angela
Gupta, Vivek
Barnett, Michael H.
Fraser, Clare L.
Gillies, Mark
Graham, Stuart L.
Klistorner, Alexander
OPHTHALMOLOGY, 2019, 126 (06) : 2019 - 810
[4] Long-term Safety and Efficacy of Eculizumab in Neuromyelitis Optica Spectrum Disorder
Wingerchuk, Dean M.
Pittock, Sean J.
Berthele, Achim
Fujihara, Kazuo
Kim, Ho Jin
Levy, Michael
Palace, Jacqueline
Nakashima, Ichiro
Terzi, Murat
Totolyan, Natalia
Viswanathan, Shanthi
Wang, Kai-Chen
Allen, Kerstin
Fujita, Kenji P.
Yountz, Marcus
Armstrong, Roisin
NEUROLOGY, 2020, 94 (15)
[5] Rituximab-induced interstitial lung disease in a patient with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder
Ahn, So Hyun
Kim, Sung-Min
Sung, Jung-Joon
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 20 : 192 - 193
[6] Clinical burden of relapses in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder: A single center cohort analysis
Kadish, Robert
Clardy, Stacey L.
Royston, Minying
Tanvir, Imran
Parker, Tavan
Biskupiak, Joseph
Kielhorn, Adrian
JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
[7] Efficacy and Safety of Eculizumab in Asian Patients WithAquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder: Subgroup Analysis From the Phase 3 PREVENT Study
Kim, H. J.
Berthele, A.
Fujihara, K.
Levy, M.
Palace, J.
Nakashima, I.
Totolyan, N.
Viswanathan, S.
Wang, K-C.
Pace, A.
Armstrong, R.
Miller, L.
Yountz, M.
Wingerchuk, D. M.
Pittock, S. J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP38 - NP39
[8] Aquaporin-4 Immunoglobulin-G Positive Neuromyelitis Optica Spectrum Disorder in a Paraneoplastic Context
Hyun, Jae-Won
Park, Na Young
Kim, Min Jeong
Kim, Haeun
Kim, Ki Hoon
Kim, Su-Hyun
Kim, Ho Jin
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 150 - 151
[9] Long-term efficacy and safety of eculizumab in aqp4+neuromyelitis optica spectrum disorder
Wingerchuk, D.
Berthele, A.
Fujihara, K.
Oreja-Guevara, C.
Kim, H. J.
Levy, M.
Nakashima, I.
Palace, J.
Shang, S.
Yountz, M.
Miller, L.
Pittock, S.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 465 - 465
[10] Regional outcomes of eculizumab treatment in patients with aquaporin-4 immunoglobin G-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study
Oreja-Guevara, C.
Palace, J.
Pittock, S. J.
Berthele, A.
Fujihara, K.
Levy, M.
Nakashima, I.
Pace, A.
Miller, L.
Sabatella, G.
Wingerchuk, D. M.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 90 - 90

← 1 2 3 4 5 →